In liver fibrosis, CDK1 may promote fibrosis through the activation of hepatic stellate cells (HSCs), whereas in hepatocellular carcinoma, it may drive tumor cell proliferation, but existing analyses often ignore cell-type specificity (e.g., without integrating single-cell sequencing data). This evidence concerns the gene CDK1 and hepatocellular carcinoma.